CAS RN: 143664-11-3
Elacridar
Product Availability
Choose a grade to view its available package options.
10 package records10 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20250218 | 100mg | In stock | Shanghai, Shenzhen, Tianjin, Wuhan | Inquiry | |
| Batchno.20250422 | 10mg | In stock | Shanghai | Inquiry | |
| Batchno.20260606 | 10mg / 50mg / 100mg / 1g | Confirm by inquiry | Shanghai, Shandong | 8-10 business days | Inquiry |
| Batchno.20250108 | 1g | In stock | Shanghai | Inquiry | |
| Batchno.20250522 | 1mg | In stock | Shanghai | Inquiry | |
| Batchno.20260124 | 250mg | In stock | Shanghai | Inquiry | |
| Batchno.20250404 | 25mg | In stock | Shanghai | Inquiry | |
| Batchno.20251016 | 50mg | In stock | Shanghai | Inquiry | |
| Batchno.20260310 | 5g | In stock | Shanghai | Inquiry | |
| Batchno.20250527 | 5mg | In stock | Shanghai | Inquiry |
- Product code: SSC-055045
Historical Factory Record
Historical Supply Reference
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
- Pack sizes on record: 1g
- Available purity: ≥95%
- Inventory rows with stock: 0
- Bulk packaging: confirmed by inquiry
Reference Pack Sizes
Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.
| Pack Size | Recorded Purity | Available Qty | Ship From | Inquiry |
|---|---|---|---|---|
| 1g | ≥95% | 0 Out of Stock | Hong Kong | Inquiry |
143664-11-3 / N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide
Basic Information
CAS
143664-11-3
Multi CAS
No
Molecular Formula
C34H33N3O5
Molecular Weight
563.600000
Exact Mass
563.242021
SMILES
COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC
InChI
InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)
InChIKey
OSFCMRGOZNQUSW-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
42
Aromatic heavy atom count
26
Fraction Csp3
0.24
Rotatable bonds
8
H-bond acceptors
6
H-bond donors
2
Molar refractivity
165.25
TPSA
92.89
LogP / Solubility
WLOGP
5.56
MLOGP
4.94
XLogP3
5.6
Consensus LogP
5.37
Log S (ESOL)
-6.77
Class (ESOL)
Insoluble
Log S (Ali)
-8.2
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.9
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.21
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.56
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5.5
Safety & Transport
GHS Hazard Statements
H413 (100%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
Precautionary Statement Codes
P273, and P501
